Clinical importance of antiphospholipid antibodies in pregnants with mycoplasma and associated infection

L. I. Maltseva , L. A. Lobova

Kazan medical journal ›› 2001, Vol. 82 ›› Issue (2) : 107 -110.

PDF
Kazan medical journal ›› 2001, Vol. 82 ›› Issue (2) : 107 -110. DOI: 10.17816/kazmj66606
Theoretical and clinical medicine
research-article

Clinical importance of antiphospholipid antibodies in pregnants with mycoplasma and associated infection

Author information +
History +
PDF

Abstract

The examination of 167 infected pregnants in I and II terms was carried out to reveal the rate of antiphospholi pid antibodies in pregnants with mycoplasma and associated infection. The pathologic level of anti phospholipid antibodies was determined in 21% of the pregnants with micoplasma and associated infection, in 22% of them the anti phospholipid syndrome was revealed. The most severe complications of pregnancy and accompanied extragenital pathology were found in women with anti phospholipid antibodies. During complex therapy the elimination of antibodies accompanying by the positive clinical dynamics of gestational process was found in some pregnants. Various complications of pregnancy which were arrested by timely treatment were found in women with associated mycoplasma infection without anti phospholipid antibodies.lt is concluded that the formation of anti phospholipid antibodies is the part of infectious process in pregnancy.        

Keywords

Kazan Medical archive

Cite this article

Download citation ▾
L. I. Maltseva, L. A. Lobova. Clinical importance of antiphospholipid antibodies in pregnants with mycoplasma and associated infection. Kazan medical journal, 2001, 82(2): 107-110 DOI:10.17816/kazmj66606

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Борхсениус С.Н., Чернова О.А. Микоплазмы. Молекулярная и клеточная биология, патогенность, диагностика. — Л., 1989.

[2]

Мальцева Л. И. Механизмы развития осложнений беременности и перинатальных повреждений плода при микоплазменной инфекции у женщин: Автореф. дисс. ... докт. мед. наук. — Казань, 1996.

[3]

Насонов Е.Л., Баранов А.А. и др. Патология сосудов при антифосфолипидном синдроме. — Ярославль, 1995.

[4]

Насонов ЕЛ., Кобылянский А.Г. и др. //Клин, мед. — 1998. — № 9. — С. 9—14.

[5]

Чернова О.А. Биохимические аспекты патогенеза при персистенции микоплазм у человека: Автореф. дисс. ...докт. биол. наук . — Казань, 1996.

[6]

Keeling D.M., Birley Н., Machin S.J. // Blood Coagulant. Fibrinol. — 1990. — Vol. 1. — P. 333—335.

[7]

Loizou S., Cazabon J.K. et al.//KKhz. And Rheum. —Vol. 40.-P. 103-108.

[8]

Mcneil HP., Simpson R.J. et al.// Proc. nat. Acad. Sci. USA. - 1990. - Vol. 87. - P. 4120-4121.

[9]

Vaarala O. //Autoimmun. — 1995. — Vol. 4. — P. 819-830.

RIGHTS & PERMISSIONS

Maltseva L.I., Lobova L.A.

AI Summary AI Mindmap
PDF

115

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/